Dr. Garg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
300 3rd Street
Cambridge, MA 02142Phone+1 617-732-5500- Is this information wrong?
Education & Training
- University of California (San Francisco)Residency, Internal Medicine, 1993 - 1996
- University of California San Francisco School of MedicineClass of 1993
Publications & Presentations
PubMed
- 26 citationsPhase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1: A Placebo-Controlled Randomized Clinical TrialYaacov Frishberg, Georges Deschênes, Jaap W. Groothoff, Sally-Anne Hulton, Daniella Magen, Jérôme Harambat, William van’t Hoff, Ulrike Lorch, Dawn S. Milliner, John C....> ;Clinical Journal of the American Society of Nephrology. 2021 May 13
- 211 citationsEffects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated AmyloidosisScott D. Solomon, David Adams, Arnt V. Kristen, Martha Grogan, Alejandra González-Duarte, Mathew S. Maurer, Giampaolo Merlini, Thibaud Damy, Michel Slama, Thomas H. Br...> ;Circulation. 2019 Jan 22
- 8 citationsThe generalizability of observational data to elderly patients was dependent on the research question in a systematic reviewCary P. Gross, Pushkal P. Garg, Harlan M. Krumholz> ;Journal of Clinical Epidemiology. 2005 Feb 1
- Join now to see all
Press Mentions
- Alnylam Presents Positive Results from the APOLLO-B Phase 3 Study of Patisiran in Patients with ATTR Amyloidosis with CardiomyopathySeptember 8th, 2022
- Patisiran Meets Primary Endpoint in Trial for ATTR Amyloidosis, CardiomyopathyAugust 4th, 2022
- Alnylam's Stock Jumps 57% After Sharing Positive News for Its Experimental RNAi TherapyAugust 3rd, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: